Skip to main content

Table 3 Surgical remission rates of patients with macroadenoma according to the Knosp grade

From: Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1–3): a retrospective cohort study conducted at a single center

  

Preoperative medical therapy

Primary surgery

P

Remission rate for GH

Total (%)

38/67 (56.7)

68/135 (50.4)

0.40

Knosp grade 0 (%)

15/21 (71.4)

37/49 (75.5)

0.72

Knosp grade 1–3 (%)

22/39 (56.4)

31/83 (37.3)

0.048

Knosp grade 4 (%)

1/7 (14.3)

0/3 (0)

~1.00

Remission rate for IGF-1a

Total (%)

25/65 (38.5)

42/125 (33.6)

0.51

Knosp grade 0 (%)

8/21 (38.1)

29/48 (60.4)

0.09

Knosp grade 1–3 (%)

16/37 (43.2)

13/74 (17.6)

0.004

Knosp grade 4 (%)

1/7 (14.3)

0/3 (0)

~1.00

  1. aIGF-1 results were not available for all patients